Prevention of contrast induced nephropathy by liposome encapsulation
碩士 === 國立中興大學 === 生醫工程研究所 === 102 === The increased use of contrast enhanced medical imaging in clinical diagnosis exaggerate the risk of contrast medium induced nephropathy (CIN), especially for patients with pre-existing renal dysfunction or chronic diseases (such as diabetes, cardiovascular disea...
Main Authors: | Pei-Hsuan Lu, 魯佩萱 |
---|---|
Other Authors: | 廖國智 |
Format: | Others |
Language: | en_US |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/71693314842527978806 |
Similar Items
-
Potential of Contrast Medium Induced Nephropathy Prevention by Liposome Encapsulation: In Vivo Mice Study
by: Yu-Hsiang Chou, et al.
Published: (2014) -
Influence of contrast medium encapsulated by liposome in lesion diagnosis and nephropathy prevention with computed tomography
by: Hsin-Ju Liu, et al.
Published: (2016) -
Contrast induced nephropathy: Pathophysiology and prevention
by: Sudarshan Kumar Vijay, et al.
Published: (2013-01-01) -
Effect of liposome formula and size in contrast medium induced nephropathy prevention and lesion malignancy diagnosis with computed tomography
by: Yu-Cheng Chang, et al.
Published: (2015) -
Is Nebivolol Really Effective in Preventing Contrast Induced Nephropathy?
by: Orcun Altunoren, et al.
Published: (2015-10-01)